Directori de persones
Aureli Esquerda Serrano

Aureli Esquerda Serrano

Grau: Doctor/a


aesquerda.lleida.ics(ELIMINAR)@gencat.cat

Grups

Publicacions

  • Porcel, J. M.; Ordi-Ros, J.; Esquerda, A.; Vives, M.; Madronero, A. B.; Bielsa, S.; Vilardell-Tarres, M.; Light, R. W.

    Antinuclear antibody testing in pleural fluid for the diagnosis of lupus pleuritis.

    Lupus 16 25-27. .

    [doi:10.1177/0961203306074470]

  • Porcel, J. M.; Pena, J. M.; Vicente de Vera, C.; Esquerda, A.; Vives, M.; Light, Richard W.

    Bayesian analysis using continuous likelihood ratios for identifying pleural exudates.

    RESPIRATORY MEDICINE 100 1960-1965. .

    [doi:10.1016/j.rmed.2006.02.025]

  • Porcel, JM; Salud, A; Nabal, M; Vives, M; Esquerda, A; Rodriguez-Panadero, F

    Rapid pleurodesis with doxycycline through a small-bore catheter for the treatment of metastatic malignant effusions.

    SUPPORTIVE CARE IN CANCER 14 475-478. .

    [doi:10.1007/s00520-005-0001-x]

  • Porcel, JM; Vives, M; Esquerda, A; Ruiz, A

    Usefulness of the British Thoracic Society and the American College of Chest Physicians guidelines in predicting pleural drainage of non-purulent parapneumonic effusions.

    RESPIRATORY MEDICINE 100 933-937. .

    [doi:10.1016/j.rmed.2005.06.017]

  • Porcel JM; Peña JM; Vicente de Vera C; Esquerda A

    Revaluación del método estándar (criterios de Light) para identificar exudados pleurales.

    MEDICINA CLINICA 126 211-213. .

  • Porcel, JM; Salud, A; Vives, M; Esquerda, A; Rodriguez-Panadero, F

    Soluble oncoprotein 185HER-2 in pleural fluid has limited usefulness for the diagnostic evaluation of malignant effusions.

    CLINICAL BIOCHEMISTRY 38 1031-1033. .

    [doi:10.1016/j.clinbiochem.2005.05.001]

  • Porcel, JA; Vives, M; Esquerda, A

    Tumor necrosis factor-alpha in parapneumonic effusion

    Chest 127 1868-1869. .

  • Porcel, JM; Vives, M; Esquerda, A; Salud, A; Perez, B; Rodriguez-Panadero, F

    Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.

    Chest 126 1757-1763. .

    [doi:10.1378/chest.126.6.1757]

  • Porcel, JM; Vives, M; Cao, G; Esquerda, A; Rubio, M; Rivas, C

    Measurement of pro-brain natriuretic peptide in pleural fluid for the diagnosis of pleural effusions due to heart failure.

    AMERICAN JOURNAL OF MEDICINE 116 417-420. .

    [doi:10.1016/j.amjmed.2003.11.008]

  • Porcel, JM; Vives, M; Esquerda, A

    Tumor necrosis factor-alpha in pleural fluid - a marker of complicated parapneumonic effusions

    Chest 125 160-164. .

    [doi:10.1378/chest.125.1.160]

  • Porcel JM; Vives M; Esquerda A

    Tumor necrosis factor-alpha in pleural fluid: a marker of complicated parapneumonic effusions.

    Chest 125 160-164. .

  • Porcel, JM; Vives, M; Esquerda, A; Rivas, MC

    Pleural protein capillary electrophoresis for the separation of transudates and exudates.

    CLIN CHEM 47 975-976. .

Projectes

  • Biopsia líquida utilizando el sobrenadante del líquido pleural y el plasma para el estudio del perfil mutacional en el cáncer de pulmón
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Perfil proteómico (Micromatrices Proteínicas) del líquido pleural en pacientes con derrame pleural maligno y Tuberculoso